Medical Use
Saphnelo (anifrolumab-fnia) is a type I interferon (IFN) receptor antagonist used to treat adults with moderate to severe systemic lupus erythematosus (SLE) who are on other lupus medications, regardless of race or ethnicity.
Recommended Dosage: Saphnelo is provided in single-dose vials and must be diluted before intravenous administration. The recommended dosage is 300 mg, given as an intravenous infusion over 30 minutes, every 4 weeks.
If a scheduled infusion is missed, it should be administered as soon as possible, ensuring at least a 14-day interval between infusions.
Warning & Precautions
Severe and sometimes fatal infections have been reported in patients using immunosuppressive agents, including Saphnelo. If an infection develops or if the patient does not respond to standard anti-infective therapy, carefully assess the patient and pause treatment until the infection resolves.
Angioedema, infusion-related reactions, and serious hypersensitivity reactions have been observed following Saphnelo administration. For patients with a known history of these reactions, consider pre-medication before infusion. If such reactions occur, promptly interrupt the infusion.
Immunosuppressants may increase the risk of malignancies. Weigh the benefits and risks in patients with known risk factors for malignancy recurrence before using Saphnelo. For those who develop malignancies, reassess the risk-benefit of continuing Saphnelo therapy.
Saphnelo 300 mg/2 mL has not been evaluated in combination with other biologic therapies, including B-cell-targeted therapies. Therefore, it is not recommended to use Saphnelo alongside other biological therapies.
Update immunizations according to current guidelines before starting Saphnelo treatment. Avoid concurrent use of live or live-attenuated vaccines in patients receiving this medication.
Documentation Availability
Documents required to import SAPHNELO to India?
SAPHNELO (anifrolumab-fnia) injections can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing SAPHNELO (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Saphnelo®?
The generic name for Saphnelo® is Anifrolumab-fnia.
Who manufactures Saphnelo®?
Saphnelo® is manufactured by AstraZeneca.
Where can I get Saphnelo injections at the best price in India?
For the best price on Saphnelo in India, contact Rx4u team.
Is Saphnelo® FDA approved?
Yes, Saphnelo® was approved by the FDA on July 30, 2021.
What are the most common side effects of Saphnelo®?
Common side effects include upper respiratory tract infections, nasopharyngitis, infusion-related reactions, bronchitis, herpes zoster, and cough.
What is the dosage and form of Saphnelo® supplied?
Saphnelo® is available as an injection: 300 mg/2 mL (150 mg/mL) in a single-dose vial for intravenous use.
What are the storage conditions for Saphnelo®?
Store Saphnelo in a refrigerator at 36 to 46°F (2 to 8°C) in its original carton to protect it from light. Do not freeze or shake it.
How to order Saphnelo® online in India?
Saphnelo® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
